Andreas Steinmeyer
Bayer (Germany) · 88 works · 8,972 citations · h-index 32
Top works
- Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
- Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D–dependent mechanism
- Vitamin D3 down‐regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen‐associated molecular patterns
- Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages
- 1,25‐dihydroxyvitamin D 3 promotes IL‐10 production in human B cells
- Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses
- Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D3
- 1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype,
- Vitamin D Analogs Differentially Control Antimicrobial Peptide/“Alarmin”Expression in Psoriasis
- Vitamin D inhibition of pro-fibrotic effects of transforming growth factor β1 in lung fibroblasts and epithelial cells
- Vitamin D regulates the phenotype of human breast cancer cells
- Targeting the vitamin D receptor inhibits the B cell‐dependent allergic immune response
- Antagonistic Action of a 25-Carboxylic Ester Analogue of 1α,25-Dihydroxyvitamin D3 Is Mediated by a Lack of Ligand-induced Vitamin D Receptor Interaction with Coactivators
- The Hit‐to‐Lead Process at Schering AG: Strategic Aspects
- The New Low Calcemic Vitamin D Analog 22-Ene-25-Oxa-Vitamin D Prominently Ameliorates T Helper Cell Type 1-Mediated Colitis in Mice
- Vitamin D3 down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production
- Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
- Osteopontin
- Different Molecular Mechanisms of Vitamin D3Receptor Antagonists
- Carboxylic ester antagonists of 1α,25-dihydroxyvitamin D3 show cell-specific actions